Point72 Hong Kong LTD Cogent Biosciences, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.92 - $9.73 $2,610 - $6,480	-666 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$5.31 - $8.7 $647 - $1,061	-122 Reduced 15.48%	666 $5,000
Q4 2021 Feb 14, 2022	BUY	$7.51 - $10.81 $5,917 - $8,518	788 New	788 $7,000
Q3 2021 Nov 15, 2021	SELL	$5.99 - $9.14 $9,032 - $13,783	-1,508 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.82 - $9.3 $11,792 - $14,024	1,508 New	1,508 $12,000

189

104M

157K

439K

Ticker COGT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,758,300
Market Cap $528M
Description
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.